Insmed Incorporated (INSM) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock is now down nearly 13% since Mar 18, 2014.
The company has seen no estimate revision in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Insmed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other medical stocks worth considering include Alexion Pharmaceuticals, Inc. (ALXN), Alkermes plc (ALKS) and ANI Pharmaceuticals, Inc. (ANIP). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment